Model Informed Drug Development Archives | Page 11 of 44 | Certara

Poster

What Sample Size to Use When Designing Paediatric Pharmacokinetic Studies? A Critical Analysis of “Precision Criteria”

CertaraAugust 22, 2019

Poster

T4.1 – Setting the framework for database and development of this database

CertaraAugust 22, 2019

Poster

Modelling Toxicodynamic Feedback is Critical in Recovering Toxicokinetics in Acetaminophen Overdose

CertaraAugust 9, 2019

Poster

Development and Performance Evaluation of a semi-mechanistic PBPK Model for Topical Ocular Delivery of Pilocarpine and Timolol to Rabbit Eye

CertaraJune 24, 2019

Poster

Transporter inhibition: modelling in-vitro Transwell Assays

CertaraJune 24, 2019

White Paper

Optimize Immuno-oncology Drug Discovery and Development Using QSP

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

CertaraJune 19, 2019

Brochure

Pirana Modeling Workbench

Pirana is a flexible and extendible modeling workbench with an intuitive graphical user interface for…

CertaraMay 28, 2019

Publication

Precision Dosing in Clinical Medicine: Present and Future

CertaraJuly 20, 2018

Publication

Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond

Apixaban is an orally available, direct, selective inhibitor of the coagulation factor Xa that reversibly…

CertaraJune 2, 2018

Publication

Optimization of Intestinal Microsomal Preparation in the Rat: A Systematic Approach to Assess the Influence of Various Methodologies on Metabolic Activity and Scaling Factors

CertaraApril 1, 2017

© 2025 Certara. All Rights Reserved. | Privacy policy